Tissue-specific alterations in insulin-like growth factor-I concentrations in response to 3,3',5-triiodo-L-thyronine supplementation in the growth hormone receptor-deficient sex-linked dwarf chicken

A selection method of chickens with blue-eggshell and dwarf traits by molecular marker-assisted selection

The blue-eggshell and dwarf traits have an important economic value in poultry production. Using a genetic aggregation-based strategy, the molecular marker-assisted selection technology was jointly used to provide a rapid breeding method for pure strain chickens simultaneously with hens exhibiting the blue-eggshell and dwarf traits. Overall, 80 male dwarf chickens and 1,000 hybrid blue-eggshell hens (F0) were used for the hybridization experiment. Subsequently, the crossing of F1 or F2 chicks was performed in succession. The F1 and F2 chicks were respectively detected by the joint molecular markers of the solute carrier organic anion transporter family, namely, 1B3 (SLCO1B3) and the growth hormone receptor (GHR) genes, which relate to blue-eggshell and dwarf traits. Meanwhile, the selection of blue-eggshell and dwarf phenotypes was used to validate the data obtained by the molecular markers. The results showed that F1 chicks included the heterozygous and wild-type of SLCO1B3, as well as the homozygous (hens) and heterozygous (roosters) of GHR. However, F2 chicks included 3 different genotypes of both SLCO1B3 and GHR. Ultimately, 196 F1 roosters (concurrently with heterozygous genotype of SLCO1B3 and GHR) and 1,073 F1 hens (concurrently with heterozygous genotype of SLCO1B3 and homozygous genotype of GHR) were obtained from the initial 10,040 F1 chicks. Further, 27 F2 roosters and 345 F2 hens, which simultaneously carried the homozygous genotype of SLCO1B3 and GHR, were screened from the initial 6,000 F2 chicks. Data obtained on the blue-eggshell and dwarf phenotypes were consistent with the results by molecular markers. Similarly, the purity verification of the strain obtained through 2 crossing experiments (F0♂ × F2♀ and F2♂ × F2♀) revealed that all chickens had the blue-eggshell and dwarf traits, supporting that the obtained F2 strain was pure. In summary, for the first time, we successfully bred a pure strain chicken with blue-eggshell and dwarf traits by jointly using the molecular markers of the SLCO1B3 and GHR genes. Our study provides a new method for the rapid cultivation of new chicken strains.

Growth prior to thermogenesis for a quick fledging of Adélie penguin chicks (Pygoscelis adeliae)

The evolutionary trade-off between tissue growth and mature function restricts the post natal development of polar birds. The present study uses an original integrative approach as it includes gene expression, plus biochemical and physiological analysis to investigate how Adélie penguin chicks achieve a rapid growth despite the energetic constraints linked to the cold and the very short breeding season in Antarctica. In pectoralis muscle, the main thermogenic tissue in birds, our data show that the transition from ectothermy to endothermy on Day 15 post- hatching is associated with substantial and coordinated changes in the transcription of key genes. While the early activation of genes controlling cell growth and differentiation (avGHR, avIGF-1R, T3Rβ) is rapidly down-regulated after hatching, the global increase in the relative expression of genes involved in thermoregulation (avUCP, avANT, avLPL) and transcriptional regulation (avPGC1α, avT3Rβ) underlie the muscular acquisition of oxidative metabolism. Adélie chicks only become real endotherms at 15 days of age with the development of an oxidative muscle phenotype and the ability to shiver efficiently. The persistent muscular expression of IGF-1 throughout growth probably acts as a local mediator to adjust muscle size and its oxidative capacity to anticipate the new physiological demands of future Dives in cold water. The up-regulation of T3Rβ mRNA levels suggests that circulating T3 may play an important role in the late maturation of skeletal muscle by reinforcing, at least in part, the paracrine action of IGF-1. From day 30, the metabolic shift from mixed substrate to lipid metabolism, with the markedly increased mRNA levels of muscle avLPL, avANT and avUCP, suggests the late development of a fatty acid-enhanced muscle non-shivering thermogenesis mechanism. This molecular control is the key to this finely-tuned strategy by which the Adélie penguin chick successfully heads for the sea on schedule.

Effects ofad libitumfeeding on performance of different strains of broiler breeders

(1) Tolerance to ad libitum feeding was compared in three genotypes of broiler breeder hens: a standard broiler breeder fed ad libitum (SA) or restricted (SR), a slow growing 'label' broiler breeder (L) and an experimental dwarf heavy broiler breeder (E). Two similar experiments were conducted in two distinct research centres. (2) Feed intake and body weight were measured every 3 weeks from hatch to 40 to 49 weeks of age. Egg production and egg abnormalities were recorded. The number of yellow follicles in ovaries was counted at the age of 32 weeks. (3) Body weight was stabilised at 2.2, 3.7 and 5.4 kg after 24 weeks of age in L, E and SA hens, respectively. Growth of the SR hens was similar to that of L up to 20 weeks and stabilised at a similar level to that of E hens after 30 weeks of age. (4) Sexual maturity was delayed by 6 weeks in restricted breeders compared to ad libitum fed hens that started to lay at 20 weeks. SA hens had low egg production and a high proportion of defective eggs, which was largely compensated for by feed restriction. However, productivity of SR hens remained lower than that of L breeders. (5) Compared to the low viability and reproductive fitness observed with SA hens, the E dwarf broiler breeder tolerated ad libitum feeding and had better egg production, fewer egg abnormalities and yellow follicles per ovary and a higher egg production. However, laying rate was still lower than that of the SR and L groups. Energy conversion (kJ/g egg) from 32 to 40 weeks of age was much higher in the SA group than in the other three groups. 6. The feasibility of feeding a dwarf broiler breeder ad libitum calls for further research on implications of specific IGF and GH-receptor expression at the level of the ovary in dw chickens.

Secretion pattern of growth hormone, prolactin, insulin and insulin-like growth factor-1 in the periparturient sow depending on the metabolic state during lactation

The aim of the study was to investigate the influence of different energy levels during a 4-week lactation on the regulation of the metabolic hormones somatotropin (GH), prolactin, insulin and insulin-like growth factor-1 (IGF-1). A total of 21 crossbred sows (German Landrace × Duroc) were cannulated for daily blood collection from 3 weeks before parturition until 2 weeks after weaning and for weekly window sampling (every 20 min for 10 h). Nineteen sows were given 2·8 kg food during late gestation, 5·0 kg food during lactation and 2·8 kg food per day after weaning and two sows were given food at a restricted level (3·0 kg) during lactation. In the 19 sows, the different energy balance was induced by allocation of different numbers of sucking piglets to the respective sows. One group of sows suckled seven piglets and served as a control (C; no. = 7) and another group suckled 10 to 12 piglets and was energy deficient (D). After the study, the sows of the deficient group were, based on their litter weight gain from parturition until weaning, divided into low (D-L; no. = 6) or high (D-H; no. = 6) litter weight gain. The D-H sows lost more body weight during lactation than C and had lower glucose and higher nonesterified fatty acids levels before morning feeding. GH and prolactin increased around parturition and their secretory profiles during lactation were altered by the frequent sucking stimulus, whereby the access of the piglets to their dams was not controlled. During lactation, GH and prolactin were highest in D-H sows. The results suggest a possible role of not only GH but also of prolactin in nutrient partitioning to the mammary gland just before the start of lactation and for minimizing the adverse effects of a negative energy balance. Furthermore, insulin and IGF-1 increased around parturition in all sows. Insulin was higher before and after feeding and the highest levels were found in C and D-L sows. The regulation patterns of insulin and IGF-1 indicate that the lactating sow is able to mobilize enough energy from body reserves to prevent metabolic disorders, even during a period with deficient energy supply. This is contrary to the regulation in the dairy cow, where the negative energy balance is coupled with a severe glucose deficit during phases of high milk yield, which causes decreased levels of insulin and IGF-1. In the sow, the glucose intake with the food meets the glucose requirement for metabolic pathways also during a deficient lactational energy intake. Therefore, in sows IGF-1 can be stimulated by increased GH levels via the GH receptor in the liver during a state of nutritional energy deficiency and the fact that sows can compensate a deficient metabolic state much better than cows is also reflected in the respective endocrinology.

Effect of circulating growth hormone on muscle IGF-I protein concentration in female mice with growth hormone receptor gene disruption

Growth hormone (GH) is a potent secretague for circulating insulin-like growth factor-I (IGF-I). The purpose of this study was to examine the effect of circulating GH on muscle IGF-I protein expression using GH transgenic animal models. Three different models were used: mice that overexpress bovine GH (bGH; n=10), mice without a functional GH receptor (GHR-/-; n=10), and wildtype mice (n=10). All mice were 16-week old females and each group differed in their basic phenotypic characteristics. Immediately after euthanization the triceps surae muscle group (soleus, plantaris, and gastrocnemius muscles) was removed. IGF-I was extracted from the muscle with an acid-ethanol solution (12.5% 2N hydrochloric acid and 87.5% ethanol, pH 1.5) followed by neutralization with Tris-base and subsequently quantified using a radioimmunoassay. Analysis revealed that bGH mice had significantly greater muscle IGF-I protein expression compared to GHR-/- and wildtype mice. No difference in IGF-I protein concentration was found between GHR-/- and wildtype animals. This study found that overexpression of GH leading to high circulating GH concentrations increase muscle IGF-I protein expression. However, the absence of a functional GHR did not affect muscle IGF-I protein expression compared to wildtype despite high circulating levels of GH and low circulating levels of IGF-I. In conclusion, it appears that at rest high circulating levels of GH augment muscle IGF-I protein expression only in the presence of an intact GHR but that the absence of a functional GH receptor does not affect basal levels of muscle IGF-I protein in female mice.

Internalization of the chicken growth hormone receptor complex and its effect on biological functions

In the chicken, as in mammals, GH is a pleiotropic cytokine that plays a central role in growth differentiation and metabolism by altering gene expression in target cells. In the growing and adult chicken it stimulates gene expression of IGF-I and inhibits gene transcription of the type III deiodinating enzyme (D3) and by doing so also increases T(3) concentrations. GH binding to its receptor leads to internalization of the GH-GHR complex to the Golgi apparatus. This process is linked to the episodic release pattern of GH during growth. At the same time, a sharp decline of the expression of cGHR occurs at hatching. An in vitro study using a COS-7 cell line transfected with the cDNA of the chicken GHR, revealed that GHR immunofluorescence was found in the perinuclear region and on the plasma membrane. Following GH-induced internalization, GH and GHR were colocalized in endocytic and later in large lysosomal vesicles. Neither receptor nor ligand was transferred to the nucleus as confirmed by confocal laser microscopy. The JAK/STAT pathway however, as reported for mammalian GH receptors, mediated GH-induced gene transcription in chickens.

New insights into the mechanism and actions of growth hormone (GH) in poultry

Despite well documented anabolic effects of GH in mammals, a clear demonstration of such responses in domestic poultry is lacking. Recently, comprehensive dose-response studies of GH have been conducted in broilers during late post-hatch development (8 to 9 weeks of age). GH reduced feed intake (FI) and body weight gain in a dose-dependent manner, whereas birds pair-fed to the level of voluntary FI of GH-infused birds did not differ from controls. The reduction in voluntary FI may involve centrally mediated mechanisms, as hypothalamic neuropeptide Y protein and mRNA were reduced with GH, coincident with the maximal depression in FI. Growth of breast muscle was also reduced in a dose-dependent manner. Circulating IGF-I was not enhanced by GH, despite evidence that early events in the GH signaling pathway were intact. A GH dose-dependent increase in circulating 3,3',5-triiodothyronine(T3) paralleled decreases in hepatic 5D-III monodeiodinase activity, whereas 5'D-I activity was not altered. This confirms that a marked hyperthyroid response to GH occurs in late posthatch chickens, resulting from a decrease in the degradative pathway of T3 metabolism. This secondary hyperthyroidism would account for the decreased skeletal muscle mass (52) and lack of enhanced IGF-I (53) in GH-treated birds. Based upon these studies, it is now evident that GH does in fact have significant effects in poultry, but metabolic responses may confound the anabolic potential of the hormone.

The regulation of GH-dependent hormones and enzymes after feed restriction in dwarf and control chickens

The principal objective of this study was to examine the GH-dependency of IGF-I and IGF-II changes in the chicken. To this end, the regulation of GH-dependent hormones and enzymes were studied in undernourished normal and dwarf chickens. The dwarf chickens examined exhibit a Laron-type dwarfism and have been shown to be GH receptor deficient. Thus, they provide an interesting model to determine the GH-dependency of IGF-I and IGF-II changes. Short (1 day) and long-term (7 days) feed restriction was imposed on growing normal and dwarf chickens to follow the subsequent endocrine changes. Since short-term feed restriction of dwarf chickens resulted in decreased plasma IGF-I, it appears that this is not a GH-dependent effect. However, with longer term undernutrition, IGF-I was not decreased in dwarf chickens. So, after a longer restriction period, the regulation of these factors appears to become more GH-dependent. IGF-II was not depressed at all by feed restriction in the dwarf chicken, suggesting a degree of GH-dependency.

Absence of growth hormone-induced avian muscle growth in vivo

Growth hormone (GH) clearly has the potential to dramatically enhance skeletal muscle accretion in red meat animals such as swine. It is generally accepted that this anabolic effect is mediated by insulin-like growth factor-I (IGF-I), a potent stimulator of proliferation and differentiation of satellite cells that are important for myofiber hypertrophy and for regeneration in postnatal muscle tissue. All available evidence suggests that the capacity for IGF-I-mediated actions of GH on avian myogenic cells is intact, and recent evidence is accumulating that GH may even have direct effects on avian skeletal muscle satellite cell proliferation and differentiation. However, with little exception, exogenous GH does not improve skeletal muscle mass, carcass protein, or any measure of muscle anabolism in domestic poultry. A primary lesion would appear to be the inability of GH to induce significant increases in circulating IGF-I concentrations in sexually immature, growing poultry. This is the case despite clear evidence of GH binding to hepatic receptors, GH-induced tyrosine phosphorylation of Janus kinase 2 (JAK2), and GH-induced expression of hepatic IGF-I mRNA and protein. Factors that should be explored with respect to this apparent discrepancy are discussed, including the regulation of IGF-I release, uptake, and interaction with cell-associated IGF binding proteins or receptors. In addition to its growth-promoting effects via IGF-I, GH has direct metabolic effects that are expressed as changes in circulating regulatory hormone and metabolite concentrations. The possibility that such changes may influence IGF-I release and action is also proposed.